At the GNC, we aim to improve understanding of the pathogenesis of neurological and psychiatric diseases, to identify potential novel drug targets, to develop innovative and commercialisable therapeutics, and ultimately to bring these therapies to the patients. The critical mass of researchers within the GNC allows for the study of various disease areas at multiple levels, employing a range of multidisciplinary approaches including molecular biology, genetics, neurochemistry, neurophysiology, neuroimaging and neuroanatomy, neuropharmacology, biomaterials, tissue engineering, behaviour, psychology and clinical intervention.
“NUI Galway has built an excellent reputation for high quality neuroscience research and clearly provides a superb environment for training the next generation of neuroscientists”
Professor David Nutt, President of the European Brain Council